Filing Details

Accession Number:
0001445064-15-000034
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-17 18:40:51
Reporting Period:
2015-02-13
Filing Date:
2015-02-17
Accepted Time:
2015-02-17 18:40:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1567892 Mallinckrodt Plc MNK Pharmaceutical Preparations (2834) 981088325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1223697 M Don Bailey 675 Mcdonnell Blvd.
Hazelwood MO 63042
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-02-13 33,891 $10.73 170,496 No 4 M Direct
Ordinary Shares Disposition 2015-02-13 12,091 $114.20 158,405 No 4 S Direct
Ordinary Shares Disposition 2015-02-13 21,800 $114.87 136,605 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Options (Rights to Buy) Disposition 2015-02-13 33,891 $0.00 33,891 $10.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-02-16 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 26, 2014.
  2. This represents the weighted average price paid for the shares. The shares were sold at prices ranging from $113.51 to $114.50, inclusive. Mr. Bailey will provide, upon request of the SEC staff, Mallinckrodt plc, or a shareholder of Mallinckrodt plc complete information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) - (3) to this Form 4.
  3. This represents the weighted average price paid for the shares. The shares were sold at prices ranging from $114.51 to $115.37, inclusive.
  4. Represents options to purchase shares of Questcor Pharmaceuticals, Inc. that were converted into options to purchase ordinary shares of Mallinckrodt plc pursuant to the Agreement and Plan of Merger, dated as of April 5, 2014, by and among Mallinckrodt plc ("Mallinckrodt"), Questcor Pharmaceuticals, Inc. ("Questcor") and Quincy Merger Sub, Inc. All unvested options were accelerated on August 14, 2014 in connection with the acquisition of Questcor by Mallinckrodt.